Home
>
National Drug Code (NDC)
>
PERJETA
PERJETA - 50242-145-01 - (Pertuzumab)
Drug Information of PERJETA
| Product NDC: | 50242-145 |
| Proprietary Name: | PERJETA |
| Non Proprietary Name: | Pertuzumab |
| Active Ingredient(s): | 30 mg/mL & nbsp; Pertuzumab |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PERJETA
| Product NDC: | 50242-145 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125409 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20120608 |
Package Information of PERJETA
| Package NDC: | 50242-145-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) > 14 mL in 1 VIAL, SINGLE-USE |
NDC Information of PERJETA
| NDC Code | 50242-145-01 |
| Proprietary Name | PERJETA |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) > 14 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 50242-145 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pertuzumab |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120608 |
| Marketing Category Name | BLA |
| Labeler Name | Genentech, Inc. |
| Substance Name | PERTUZUMAB |
| Strength Number | 30 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | HER2 Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA] |
